video
2dn
video2dn
Найти
Сохранить видео с ютуба
Категории
Музыка
Кино и Анимация
Автомобили
Животные
Спорт
Путешествия
Игры
Люди и Блоги
Юмор
Развлечения
Новости и Политика
Howto и Стиль
Diy своими руками
Образование
Наука и Технологии
Некоммерческие Организации
О сайте
Видео ютуба по тегу Bharat Biotech Covaxin News
COVID-19 News: Bharat Biotech Seeks Emergency Use Approval For Covaxin
Coronavirus Vaccine| Bharat Biotech's Top Brass Slams Covaxin Critics| Covid-19 News | Covid Vaccine
Covid-19 Live News: Bharat Biotech Submits Covaxin's Phase-3 Trial Data To DCGI | Breaking News
Bharat Biotech's Covaxin Shows Promising Results | Coronavirus Vaccine Update
Bharat Biotech Concludes Phase 3 trial Of Covaxin Records 77.8% Efficacy Rate
Bharat Biotech's Covaxin: All You Need To Know About Covid Vaccine | India Today
COVID-19 News: Expert Panel Reviews Bharat Biotech Vaccine For Emergency Use
Bharat Biotech's Covaxin Goes For WHO Nod Tomorrow | Breaking News | India Today
Bharat Biotech Seeks Emergency Use Authorisation For Covid Vaccine Covaxin In India
Crucial WHO Meeting On Bharat Biotech's Covaxin Approval Concludes | Breaking News
Bharat Biotech's Covaxin Show Promising Results; Well Tolerated In All Groups In Phase 1 & 2 Trials
India's first indigenous vaccine 'Covaxin' gets expert panel's nod | Bharat Biotech | World News
Bharat Biotech announces Covaxin's efficacy rate after final stage trials | COVID-19 Vaccine | News
Bharat Biotech's Covaxin To Get WHO Nod Soon By End Of September | Breaking News
Bharat Biotech Announces Phase 3 Results of Covaxin, Says It Shows Interim Efficacy of 81%| Breaking
India Today Reporter Kumar Abhishek Gets 2nd Dose Of Bharat Biotech's Covaxin| Covid Vaccine Update
Bharat Biotech's Covaxin Neutralises Double Mutant Strain, Claims ICMR Study | Breaking News
Bharat Biotech’s COVAXIN gets nod for phase 2/3 trials on 2-18 years old | Latest English News
India: Bharat Biotech latest to seek emergency use authorisation | Covaxin | COVID-19 Vaccine
No Approval For Bharat Biotech's Covaxin; Subject Expert Committee Asks For More Data| Breaking News
Следующая страница»